RN7SL251P

Across TCGA pan-cancer cohorts, RN7SL251P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL251P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RN7SL251P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL251P is over-expressed in tumor, although a few such as THCA and BLCA show the opposite, repressed pattern.

THCA, BLCA, and KIRC are the cancer types where RN7SL251P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL251P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	III,IV	−0.766	<.001	10	view →
BLCA	All	III,IV	−0.130	.021	4	view →
KIRC	All	All	−0.023	.004	3	view →
LIHC	All	All	+0.135	.010	2	view →
LUSC	All	All	+0.062	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL251P–THCA

Open the THCA breakdown →